These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

393 related items for PubMed ID: 24395223

  • 21. Polymyxin B in Combination with Rifampin and Meropenem against Polymyxin B-Resistant KPC-Producing Klebsiella pneumoniae.
    Diep JK, Jacobs DM, Sharma R, Covelli J, Bowers DR, Russo TA, Rao GG.
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872078
    [Abstract] [Full Text] [Related]

  • 22. In vitro synergistic activity of fosfomycin in combination with meropenem, amikacin and colistin against OXA-48 and/or NDM-producing Klebsiella pneumoniae.
    Erturk Sengel B, Altinkanat Gelmez G, Soyletir G, Korten V.
    J Chemother; 2020 Sep; 32(5):237-243. PubMed ID: 32228228
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Activity of Colistin in Combination with Meropenem, Tigecycline, Fosfomycin, Fusidic Acid, Rifampin or Sulbactam against Extensively Drug-Resistant Acinetobacter baumannii in a Murine Thigh-Infection Model.
    Fan B, Guan J, Wang X, Cong Y.
    PLoS One; 2016 Sep; 11(6):e0157757. PubMed ID: 27315107
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Time kill-assays of antibiotic combinations for multidrug resistant clinical isolates of OXA-48 carbapenemase producing Klebsiella pneumoniae.
    Erdem F, Díez-Aguilar M, Oksuz L, Kayacan C, Abulaila A, Oncul O, Morosini MI, Cantón R, Aktas Z.
    Acta Microbiol Immunol Hung; 2022 Sep 16; 69(3):215-219. PubMed ID: 35895557
    [Abstract] [Full Text] [Related]

  • 30. In vitro pharmacodynamics of simulated pulmonary exposures of tigecycline alone and in combination against Klebsiella pneumoniae isolates producing a KPC carbapenemase.
    Wiskirchen DE, Koomanachai P, Nicasio AM, Nicolau DP, Kuti JL.
    Antimicrob Agents Chemother; 2011 Apr 16; 55(4):1420-7. PubMed ID: 21282442
    [Abstract] [Full Text] [Related]

  • 31. Evaluation of polymyxin B in combination with 13 other antibiotics against carbapenemase-producing Klebsiella pneumoniae in time-lapse microscopy and time-kill experiments.
    Wistrand-Yuen P, Olsson A, Skarp KP, Friberg LE, Nielsen EI, Lagerbäck P, Tängdén T.
    Clin Microbiol Infect; 2020 Sep 16; 26(9):1214-1221. PubMed ID: 32224200
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. In Vitro Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii.
    Bae S, Kim MC, Park SJ, Kim HS, Sung H, Kim MN, Kim SH, Lee SO, Choi SH, Woo JH, Kim YS, Chong YP.
    Antimicrob Agents Chemother; 2016 Nov 16; 60(11):6774-6779. PubMed ID: 27600048
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Efficacy of tigecycline alone or in combination for experimental infections by KPC carbapenemase-producing Klebsiella pneumoniae.
    Fergadaki S, Renieris G, Machairas N, Sabracos L, Droggiti DI, Misiakos E, Giamarellos-Bourboulis EJ.
    Int J Antimicrob Agents; 2021 Sep 16; 58(3):106384. PubMed ID: 34161789
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. In vitro pharmacodynamics of various antibiotics in combination against extensively drug-resistant Klebsiella pneumoniae.
    Lim TP, Cai Y, Hong Y, Chan EC, Suranthran S, Teo JQ, Lee WH, Tan TY, Hsu LY, Koh TH, Tan TT, Kwa AL.
    Antimicrob Agents Chemother; 2015 May 16; 59(5):2515-24. PubMed ID: 25691628
    [Abstract] [Full Text] [Related]

  • 40. Evaluation of ceftazidime/avibactam alone and in combination with amikacin, colistin and tigecycline against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae by in vitro time-kill experiment.
    Wang F, Zhou Q, Yang X, Bai Y, Cui J.
    PLoS One; 2021 May 16; 16(10):e0258426. PubMed ID: 34648556
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.